Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

Autor: H M, Colhoun, S J, Livingstone, H C, Looker, A D, Morris, S H, Wild, R S, Lindsay, C, Reed, P T, Donnan, B, Guthrie, G P, Leese, J, McKnight, D W M, Pearson, E, Pearson, J R, Petrie, S, Philip, N, Sattar, F M, Sullivan, P, McKeigue, R, McAlpine

Publikováno v: Diabetologia
Colhoun, H, Livingstone, S J, Looker, H C, Morris, A D, Wild, S H, Lindsay, R S, Reed, C, Donnan, P T, Guthrie, B, Leese, G P, McKnight, J, Pearson, D W M, Pearson, E, Petrie, J R, Philip, S, Sattar, N & Sullivan, F M & McKeigue, P 2012, ' Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs ', Diabetologia, vol. 55, no. 11, pp. 2929-2937 . https://doi.org/10.1007/s00125-012-2668-0

AIMS/HYPOTHESIS: Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predominantly for distal fractures in women. We examined whether exposure to TZDs affects hip fracture in women and men and compared the risk to that foun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f715694d7e9f77cfdd0fa7e6c2f577d2
https://doi.org/10.1007/s00125-012-2668-0

Barriers to physical activity in patients with diabetes

Autor: E Alder, G P Leese, Nihal Thomas

Publikováno v: Postgraduate Medical Journal. 80:287-291

Purpose Two questions were addressed: (1) How much physical activity do patients with diabetes perform? (2) What are the perceived factors that prevent patients from doing more physical activity? Research design and methods Interview based questionna

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb179455db05dfceca5a67dc45ffb653
https://doi.org/10.1136/pgmj.2003.010553

Diabetes Festival: 11–12 November 1999

Autor: F. C. Green, G. P. Leese

Publikováno v: Journal of the Royal College of Physicians of Edinburgh. 30:316-320

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54c998ba52c4f7607397209adf64f277
https://doi.org/10.1177/147827150003000409

Measuring the accuracy of different ways to identify the 'at-risk' foot in routine clinical practice

Autor: G P, Leese, L, Cochrane, A D R, Mackie, D, Stang, K, Brown, V, Green

Publikováno v: Diabetic medicine : a journal of the British Diabetic Association. 28(6)

We aimed to identify which individual risk factors best predict foot ulceration in routine clinical practice and whether an integrated clinical tool is a better screening tool for future foot ulceration.Routinely collected clinical information on foo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d3249faa7099b6c38652f6e9c2b2b030
https://pubmed.ncbi.nlm.nih.gov/21418097

Do patients with diabetes wear shoes of the correct size?

Autor: S J, Harrison, L, Cochrane, R J, Abboud, G P, Leese

Publikováno v: International journal of clinical practice. 61(11)

Fifteen per cent of patients with diabetes will develop a foot ulcer at some point in their life. Ill-fitting footwear frequently contributes to foot ulceration. A good fitting shoe is an essential component in the management of the diabetic foot. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eba15ddc0429fafff5938547e0ba1f7c
https://pubmed.ncbi.nlm.nih.gov/17935543